BRPI0910833A2 - Derivado de arilpirazinona como estimuladores da secreção de insulina, métodos para obtenção dos mesmos e uso dos mesmos para o tratamento de diabetes - Google Patents
Derivado de arilpirazinona como estimuladores da secreção de insulina, métodos para obtenção dos mesmos e uso dos mesmos para o tratamento de diabetesInfo
- Publication number
- BRPI0910833A2 BRPI0910833A2 BRPI0910833-5A BRPI0910833A BRPI0910833A2 BR PI0910833 A2 BRPI0910833 A2 BR PI0910833A2 BR PI0910833 A BRPI0910833 A BR PI0910833A BR PI0910833 A2 BRPI0910833 A2 BR PI0910833A2
- Authority
- BR
- Brazil
- Prior art keywords
- arylpyrazinone
- derivative
- obtaining
- methods
- insulin secretion
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08008165 | 2008-04-29 | ||
PCT/EP2009/002328 WO2009132739A1 (en) | 2008-04-29 | 2009-03-31 | Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0910833A2 true BRPI0910833A2 (pt) | 2015-08-11 |
Family
ID=40589704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0910833-5A BRPI0910833A2 (pt) | 2008-04-29 | 2009-03-31 | Derivado de arilpirazinona como estimuladores da secreção de insulina, métodos para obtenção dos mesmos e uso dos mesmos para o tratamento de diabetes |
Country Status (25)
Country | Link |
---|---|
US (2) | US8815859B2 (pt) |
EP (1) | EP2268624B1 (pt) |
JP (1) | JP5498482B2 (pt) |
KR (1) | KR101687419B1 (pt) |
CN (1) | CN102015661B (pt) |
AR (1) | AR071518A1 (pt) |
AU (1) | AU2009242720B2 (pt) |
BR (1) | BRPI0910833A2 (pt) |
CA (1) | CA2722813C (pt) |
CO (1) | CO6310997A2 (pt) |
CY (1) | CY1114531T1 (pt) |
DK (1) | DK2268624T3 (pt) |
EA (1) | EA022345B1 (pt) |
EC (1) | ECSP10010642A (pt) |
ES (1) | ES2433210T3 (pt) |
HR (1) | HRP20130992T1 (pt) |
IL (1) | IL208959A (pt) |
MX (1) | MX2010011792A (pt) |
NZ (1) | NZ589555A (pt) |
PL (1) | PL2268624T3 (pt) |
PT (1) | PT2268624E (pt) |
SI (1) | SI2268624T1 (pt) |
UA (1) | UA103191C2 (pt) |
WO (1) | WO2009132739A1 (pt) |
ZA (1) | ZA201008505B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2736472A1 (en) * | 2008-09-26 | 2010-04-01 | F. Hoffmann-La Roche Ag | Pyrine or pyrazine derivatives for treating hcv |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013066838A1 (en) * | 2011-10-31 | 2013-05-10 | Glaxosmithkline Llc | Compounds and methods |
CN104628661A (zh) * | 2015-02-05 | 2015-05-20 | 北京理工大学 | 一类喹喔啉酮衍生物作为醛糖还原酶抑制剂的结构、制备方法及用途 |
CN114907323B (zh) * | 2022-05-31 | 2023-08-15 | 内蒙古民族大学 | 喹喔啉酮类化合物及其制备方法和应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62198671A (ja) | 1986-02-25 | 1987-09-02 | Toyo Jozo Co Ltd | 1−置換アルキル1,2−ジヒドロ−2−ピラジノン誘導体 |
CA2446980A1 (en) * | 2001-05-14 | 2002-11-21 | Argyrios G. Arvanitis | Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
NZ537629A (en) | 2002-07-19 | 2007-05-31 | Biovitrum Ab | Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders |
FR2857867B1 (fr) * | 2003-07-25 | 2005-10-14 | Oreal | Utilisation en coloration capillaire de derives de ninhydrine portant un groupe heteroalkyle |
EP1732564A1 (en) | 2004-03-29 | 2006-12-20 | Merck & Co., Inc. | Biaryl substituted pyrazinones as sodium channel blockers |
NZ555419A (en) * | 2004-11-03 | 2009-07-31 | Curis Inc | Mediators of the hedgehog gene signaling pathways, compositions and uses related thereto |
TW200640881A (en) * | 2005-02-15 | 2006-12-01 | Du Pont | Fungicidal pyrazine derivatives |
ES2412007T3 (es) | 2005-12-21 | 2013-07-09 | Janssen Pharmaceutica, N.V. | Derivados de pirazinona sustituida novedosos para uso en enfermedades mediadas por MCH-1 |
AU2007261461A1 (en) | 2006-06-21 | 2007-12-27 | E. I. Du Pont De Nemours And Company | Pyrazinones as cellular proliferation inhibitors |
-
2009
- 2009-03-31 US US12/990,098 patent/US8815859B2/en active Active
- 2009-03-31 ES ES09737783T patent/ES2433210T3/es active Active
- 2009-03-31 CN CN200980114790.3A patent/CN102015661B/zh not_active Expired - Fee Related
- 2009-03-31 UA UAA201014234A patent/UA103191C2/ru unknown
- 2009-03-31 JP JP2011506584A patent/JP5498482B2/ja active Active
- 2009-03-31 PL PL09737783T patent/PL2268624T3/pl unknown
- 2009-03-31 WO PCT/EP2009/002328 patent/WO2009132739A1/en active Application Filing
- 2009-03-31 EP EP09737783.2A patent/EP2268624B1/en active Active
- 2009-03-31 DK DK09737783.2T patent/DK2268624T3/da active
- 2009-03-31 EA EA201001688A patent/EA022345B1/ru not_active IP Right Cessation
- 2009-03-31 NZ NZ589555A patent/NZ589555A/xx not_active IP Right Cessation
- 2009-03-31 CA CA2722813A patent/CA2722813C/en not_active Expired - Fee Related
- 2009-03-31 KR KR1020107026410A patent/KR101687419B1/ko active IP Right Grant
- 2009-03-31 BR BRPI0910833-5A patent/BRPI0910833A2/pt not_active IP Right Cessation
- 2009-03-31 MX MX2010011792A patent/MX2010011792A/es active IP Right Grant
- 2009-03-31 PT PT97377832T patent/PT2268624E/pt unknown
- 2009-03-31 AU AU2009242720A patent/AU2009242720B2/en not_active Ceased
- 2009-03-31 SI SI200930752T patent/SI2268624T1/sl unknown
- 2009-04-29 AR ARP090101517A patent/AR071518A1/es unknown
-
2010
- 2010-10-25 CO CO10131722A patent/CO6310997A2/es not_active Application Discontinuation
- 2010-10-26 IL IL208959A patent/IL208959A/en not_active IP Right Cessation
- 2010-11-26 EC EC2010010642A patent/ECSP10010642A/es unknown
- 2010-11-26 ZA ZA2010/08505A patent/ZA201008505B/en unknown
-
2013
- 2013-10-21 HR HRP20130992AT patent/HRP20130992T1/hr unknown
- 2013-10-25 CY CY20131100943T patent/CY1114531T1/el unknown
-
2014
- 2014-07-22 US US14/337,796 patent/US9233937B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0908406A2 (pt) | Derivados de quinoxalinona como estimulantes da secreção de insulina, métodos para obtenção dos mesmos e uso dos mesmos para tratamento do diabetes | |
BRPI1012642A2 (pt) | formulação de insulina e método para o tratamento de um indivíduo diabético. | |
BRPI0921389A2 (pt) | seringa de um só uso, de inutilização automática | |
DK2328636T3 (da) | Anordning til forbedret subkutan insulinabsorption | |
BRPI0911782A2 (pt) | composição de insulina de ação super rápida | |
BRPI0907110A2 (pt) | dispositivo de injeção para realizar injeções médicas | |
BRPI0914614A2 (pt) | 2-arilaminoquinazolinas para tratar doenças proliferativas | |
BRPI0822380A2 (pt) | agulha para coleta de sangue com retrocesso | |
BRPI0908456A2 (pt) | derivados de bifenil restritos estruturalmente para uso como inibidores do vírus da hepatite c | |
BRPI0910282A2 (pt) | Composto oxadiazo-antraceno para o tratamento de diabetes | |
BR112012022879A2 (pt) | composto, composição farmacêutica, uso do composto e método de tratamento | |
DK2555807T3 (da) | Skabelon-øceller og små øcelleklynger til behandling af diabetes | |
BRPI0817198A2 (pt) | (ciclopropilfenil)feniloxalamidas, método para a produção das mesmas, e uso das mesmas como um medicamento | |
BRPI0911594A2 (pt) | di-hidropirazolonas substistuídas, seu processo de preparação e seu uso, bem como medicamentos | |
BR112012000502A2 (pt) | terapia de combinação para o tratamento de diabetes | |
CL2011002041A1 (es) | Compuestos derivaados de 4-isopropilfenilglucitol, inhibidores de sglt1; preparacion farmaceutica; y su uso como agente para mejorar la hiperglucemia posprandial y como agente profilactico o terapeutico para la diabetes. | |
BRPI0911545A2 (pt) | dispositvo para a produção de um componente assim como método e componente | |
BRPI0911077A2 (pt) | método para tratamento de biomassa | |
BRPI1007779A2 (pt) | perexilina, método para tratamento de hcm, programa de tratamento para tratar hcm e uso da perexilina | |
BRPI0908544A2 (pt) | derivados de pirazinona como estimuladores de secreção de insulina, métodos para obtenção dos mesmos, e uso dos mesmos para o tratamento de diabetes | |
BRPI1006996A2 (pt) | composição, método e uso | |
BR112012006437A2 (pt) | composições e métodos para tratamento do diabetes e outros distúrbios | |
BRPI0821827A2 (pt) | Derivados de beta-aminoácidos para tratamento de diabetes | |
BRPI0908569A2 (pt) | estimuladores de secreção de insulina derivados de piridopirazinonas, métodos para obtê-los e uso dos mesmos para o tratamento de diabetes | |
BRPI0914900A2 (pt) | compostos de amida, métodos de preparação e usos dos mesmos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2508 DE 29-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |